Mckesson Medical-Surgical Inc. Corporate Office recalls BENLYSTA (belimumab) for injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations; potential temperature excursions due to transit delays
- Products
-
- BENLYSTA (belimumab) for injection
- Where it was sold
-
Within the U.S - OH, VA, FL.
States: Florida, Ohio, Virginia
- Units affected
- 3 Vials
- About this recall
- BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.